Dynamic expression of IL-6 trans-signalling molecules in the lungs of preterm baboons undergoing mechanical ventilation

Neonatology

Volumn 100, Issue 2, 2011, Pages 130-138

  McGreal, Eamon P ^a   Chakraborty, Mallinath ^a   Winter, Vicki T ^b   Jones, Simon A ^a   Coalson, Jacqueline J ^b   Kotecha, Sailesh ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Bronchopulmonary dysplasia; Chronic lung disease of prematurity; Inflammation; Interleukin 6; Lung; Mechanical ventilation; Preterm baboons

Indexed keywords

CHEMOKINE; GLYCOPROTEIN GP 130; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; BABOON; CELL COUNT; INFLAMMATORY CELL; LUNG; LUNG ASPIRATION; MONONUCLEAR CELL; NEUTROPHIL; NEWBORN; NONHUMAN; PREMATURITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANIMALS; ANIMALS, NEWBORN; BIOLOGICAL MARKERS; CHEMOKINE CCL2; CYTOKINE RECEPTOR GP130; DISEASE MODELS, ANIMAL; FEMALE; INFLAMMATION; INTERLEUKIN-6; INTERLEUKIN-8; LUNG; LUNG DISEASES; NEUTROPHILS; PAPIO CYNOCEPHALUS; PREGNANCY; PREMATURE BIRTH; RECEPTORS, INTERLEUKIN-6; RESPIRATION, ARTIFICIAL;

PAPIO;

EID: 79952104972     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000322148     Document Type: Article

References (27)

1. Jobe AH, Bancalari E: Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163: 1723-1729. (Pubitemid 32578778)
2. Davies PL, Maxwell NC, Kotecha S: The role of inflammation and infection in the development of chronic lung disease of prematurity. Adv Exp Med Biol 2006; 582: 101-110.
3. Coalson JJ: Pathology of new bronchopulmonary dysplasia. Semin Neonatol 2003; 8: 73-81. (Pubitemid 36356495)
4. Maxwell NC, Davies PL, Kotecha S: Antenatal infection and inflammation: What's new? Curr Opin Infect Dis 2006; 19: 253-258. (Pubitemid 43740363)
5. Kotecha S, Chan B, Azam N, Silverman M, Shaw RJ: Increase in interleukin-8 and soluble intercellular adhesion molecule-1 in bronchoalveolar lavage fluid from premature infants who develop chronic lung disease. Arch Dis Child Fetal Neonatal Ed 1995; 72:F90-F96.
6. Kotecha S, Hodge R, Schaber JA, Miralles R, Silverman M, Grant WD: Pulmonary Ureaplasma urealyticum is associated with the development of acute lung inflammation and chronic lung disease in preterm infants. Pediatr Res 2004; 55: 61-68. (Pubitemid 38018693)
7. Kotecha S, Wilson L, Wangoo A, Silverman M, Shaw RJ: Increase in interleukin (IL)-1 beta and IL-6 in bronchoalveolar lavage fluid obtained from infants with chronic lung disease of prematurity. Pediatr Res 1996; 40: 250-256. (Pubitemid 26249677)
8. Rose-John S, Scheller J, Elson G, Jones SA: Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: Role in inflammation and cancer. J Leukoc Biol 2006; 80: 227-236. (Pubitemid 44835496)
9. Hurst SM, Wilkinson TS, McLoughlin RM, Jones S, Horiuchi S, Yamamoto N, Rose-John S, Fuller GM, Topley N, Jones SA: IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 2001; 14: 705-714. (Pubitemid 32592418)
10. McLoughlin RM, Hurst SM, Nowell MA, Harris DA, Horiuchi S, Morgan LW, Wilkinson TS, Yamamoto N, Topley N, Jones SA: Differential regulation of neutrophil-activating chemokines by IL-6 and its soluble receptor isoforms. J Immunol 2004; 172: 5676-5683. (Pubitemid 38542071)
11. Bagchi A, Viscardi RM, Taciak V, Ensor JE, McCrea KA, Hasday JD: Increased activity of interleukin-6 but not tumor necrosis factor- α in lung lavage of premature infants is associated with the development of bronchopulmonary dysplasia. Pediatr Res 1994; 36: 244-252. (Pubitemid 24222488)
12. Von Bismarck P, Claass A, Schickor C, Krause MF, Rose-John S: Altered pulmonary interleukin-6 signaling in preterm infants developing bronchopulmonary dysplasia. Exp Lung Res 2008; 34: 694-706.
13. Coalson JJ, Winter VT, Siler-Khodr T, Yoder BA: Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med 1999; 160: 1333-1346. (Pubitemid 29487478)
14. Viscardi RM, Atamas SP, Luzina IG, Hasday JD, He JR, Sime PJ, Coalson JJ, Yoder BA: Antenatal Ureaplasma urealyticum respiratory tract infection stimulates proinflammatory, profibrotic responses in the preterm baboon lung. Pediatr Res 2006; 60: 141-146. (Pubitemid 44297582)
15. Giuliani N, Sansoni P, Girasole G, Vescovini R, Passeri G, Passeri M, Pedrazzoni M: Serum interleukin-6, soluble interleukin-6 receptor and soluble gp130 exhibit different patterns of age- and menopause-related changes. Exp Gerontol 2001; 36: 547-557. (Pubitemid 32201509)
16. Jobe AH, Ikegami M: Mechanisms initiating lung injury in the preterm. Early Hum Dev 1998; 53: 81-94. (Pubitemid 28479747)
17. Tullus K, Noack GW, Burman LG, Nilsson R, Wretlind B, Brauner A: Elevated cytokine levels in tracheobronchial aspirate fluids from ventilator treated neonates with bronchopulmonary dysplasia. Eur J Pediatr 1996; 155: 112-116.
18. Jobe AH, Hillman N, Polglase G, Kramer BW, Kallapur S, Pillow J: Injury and inflammation from resuscitation of the preterm infant. Neonatology 2008; 94: 190-196.
19. McLoughlin RM, Witowski J, Robson RL, Wilkinson TS, Hurst SM, Williams AS, Williams JD, Rose-John S, Jones SA, Topley N: Interplay between IFN- γ and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation. J Clin Invest 2003; 112: 598-607. (Pubitemid 38056344)
20. Romani L, Mencacci A, Cenci E, Spaccapelo R, Toniatti C, Puccetti P, Bistoni F, Poli V: Impaired neutrophil response and CD4+ Thelper cell 1 development in interleukin-6- deficient mice infected with Candida albicans J Exp Med 1996; 183: 1345-1355. (Pubitemid 26134278)
21. Ulich TR, Yin S, Guo K, Yi ES, Remick D, del Castillo J: Intratracheal injection of endotoxin and cytokines. II. Interleukin-6 and transforming growth factor- α inhibit acute inflammation. Am J Pathol 1991; 138: 1097-1101.
22. Jones SA, Richards PJ, Scheller J, Rose-John S: IL-6 trans-signaling: The in vivo consequences. J Interferon Cytokine Res 2005; 25: 241-253.
23. Muller-Newen G, Kuster A, Hemmann U, Keul R, Horsten U, Martens A, Graeve L, Wijdenes J, Heinrich PC: Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses. J Immunol 1998; 161: 6347-6355. (Pubitemid 28536011)
24. Kramer BW, Ikegami M, Moss TJ, Nitsos I, Newnham JP, Jobe AH: Antenatal betamethasone changes cord blood monocyte responses to endotoxin in preterm lambs. Pediatr Res 2004; 55: 764-768. (Pubitemid 38520441)
25. Ward NS, Waxman AB, Homer RJ, Mantell LL, Einarsson O, Du Y, Elias JA: Interleukin- 6-induced protection in hyperoxic acute lung injury. Am J Respir Cell Mol Biol 2000; 22: 535-542. (Pubitemid 30319539)
26. Wolters PJ, Wray C, Sutherland RE, Kim SS, Koff J, Mao Y, Frank JA: Neutrophil-derived IL-6 limits alveolar barrier disruption in experimental ventilator-induced lung injury. J Immunol 2009; 182: 8056-8062.
27. Xing Z, Gauldie J, Cox G, Baumann H, Jordana M, Lei XF, Achong MK: IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 1998; 101: 311-320. (Pubitemid 28067327)